SEC Form 4 · accession 0001140361-17-013496
KalVista Pharmaceuticals, Inc. · KALV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Aldrich
Director
Period of report
Mar 23, 2017
Accepted (ET)
Mar 27, 2017 · 7:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348911
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy)F1 | $7.88 | Mar 23, 2017 | A | 12,000 | A | — | Mar 22, 2027 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1The option vests over a 3 year period: 1/36th on December 21, 2016 after which 1/36th of the total shares vest monthly, subject to continued service through each vesting date.